Paula Reichel
Overview
Explore the profile of Paula Reichel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
259
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schaier M, Kalble F, Benning L, Reichel P, Mahler C, Nusshag C, et al.
Rheumatol Int
. 2025 Mar;
45(3):68.
PMID: 40029448
The ANCA-associated vasculitis (AAV) has an exceptionally high morbidity and mortality especially in patients with diffuse alveolar hemorrhage (DAH). Data on DAH in elderly AAV patients is still very limited....
2.
Benning L, Bartenschlager M, Kim H, Kalble F, Nusshag C, Buylaert M, et al.
J Med Virol
. 2023 Dec;
95(12):e29303.
PMID: 38082556
The development of bivalent booster vaccines addresses the ongoing evolution of the emerging B.1.1.529 (omicron) variant subtypes that are known to escape vaccine-induced neutralizing antibody response. Little is known about...
3.
Speer C, Tollner M, Benning L, Bartenschlager M, Kim H, Nusshag C, et al.
Viruses
. 2023 Aug;
15(8).
PMID: 37632120
Emerging omicron subtypes with immune escape lead to inadequate vaccine response with breakthrough infections in immunocompromised individuals such as Anti-neutrophil Cytoplasmic Antibody (ANCA)-associated vasculitis (AAV) patients. As AAV is considered...
4.
Benning L, Morath C, Bartenschlager M, Kim H, Reineke M, Beimler J, et al.
Am J Transplant
. 2022 Apr;
22(7):1873-1883.
PMID: 35384272
Seroconversion after COVID-19 vaccination is impaired in kidney transplant recipients. Emerging variants of concern such as the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants pose an increasing threat to these...
5.
Benning L, Klein K, Morath C, Bartenschlager M, Kim H, Buylaert M, et al.
Front Immunol
. 2022 Mar;
13:840136.
PMID: 35309320
Hemodialysis patients are at high risk for severe COVID-19, and impaired seroconversion rates have been demonstrated after COVID-19 vaccination. Humoral immunity wanes over time and variants of concern with immune...
6.
Benning L, Morath C, Bartenschlager M, Reineke M, Tollner M, Nusshag C, et al.
Clin Microbiol Infect
. 2022 Feb;
28(7):1024.e7-1024.e12.
PMID: 35124261
Objectives: Humoral immunity wanes over time after two-dose BNT162b2 vaccination. Emerging variants of concern, such as the B.1.617.2 (delta) variant, are increasingly responsible for breakthrough infections owing to their higher...
7.
Speer C, Tollner M, Benning L, Klein K, Bartenschlager M, Nusshag C, et al.
Ann Rheum Dis
. 2022 Jan;
81(4):593-595.
PMID: 35012926
No abstract available.
8.
Benning L, Morath C, Bartenschlager M, Reineke M, Tollner M, Nusshag C, et al.
Kidney Int
. 2021 Dec;
101(3):639-642.
PMID: 34954213
No abstract available.
9.
Benning L, Morath C, Bartenschlager M, Nusshag C, Kalble F, Buylaert M, et al.
Clin J Am Soc Nephrol
. 2021 Dec;
17(1):98-106.
PMID: 34937771
Background And Objectives: Antibody response after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination is impaired in kidney transplant recipients. Emerging variants, such as B.1.617.2 (), are of particular concern...
10.
Speer C, Schaier M, Nusshag C, Tollner M, Buylaert M, Kalble F, et al.
Vaccines (Basel)
. 2021 Oct;
9(10).
PMID: 34696238
It has been demonstrated that patients on hemo- or peritoneal dialysis are particularly susceptible to SARS-CoV-2 infection and impaired seroconversion compared to healthy controls. Follow-up data on vaccination response in...